Report overview
This report contains market size and forecasts of Immunosuppressive Drugs in global, including the following market information:
Global Immunosuppressive Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Immunosuppressive Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Immunosuppressive Drugs companies in 2021 (%)
The global Immunosuppressive Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Calcineurin Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Immunosuppressive Drugs include Pfizer, Sanofi, Novartis, Roche, Astellas Pharma, Inc., GlaxoSmithKline plc, Veloxis Pharmaceuticals, Mylan and Dr Reddys Laboratories and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Immunosuppressive Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immunosuppressive Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Immunosuppressive Drugs Market Segment Percentages, by Type, 2021 (%)
Calcineurin Inhibitors
Antiproliferative Agents
mTOR Inhibitors
Antibodies
Steroids
Global Immunosuppressive Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Immunosuppressive Drugs Market Segment Percentages, by Application, 2021 (%)
Kidney Transplant
Bone Marrow Transplant
Liver Transplant
Heart Transplant
Lungs Transplant
Others Transplant
Global Immunosuppressive Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Immunosuppressive Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immunosuppressive Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Immunosuppressive Drugs revenues share in global market, 2021 (%)
Key companies Immunosuppressive Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Immunosuppressive Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Sanofi
Novartis
Roche
Astellas Pharma, Inc.
GlaxoSmithKline plc
Veloxis Pharmaceuticals
Mylan
Dr Reddys Laboratories
Abbvie Inc
